Nabriva Therapeutics Stock Forecast - Day Median Price

NBRVDelisted Stock  USD 1.62  0.01  0.61%   
Nabriva Stock Forecast is based on your current time horizon.
  
Nabriva Therapeutics AG has current Day Median Price of 1.63. Median Price is the statistical median of an asset price for a given trading period.
Check Nabriva Therapeutics VolatilityBacktest Nabriva TherapeuticsInformation Ratio  

Nabriva Therapeutics Trading Date Momentum

On December 03 2024 Nabriva Therapeutics AG was traded for  1.62  at the closing time. The top price for the day was 1.63  and the lowest listed price was  1.62 . There was no trading activity during the period 0.0. Lack of trading volume on December 3, 2024 did not cause price change. The trading delta at closing time against the current closing price is 0.62% .
The median price is the midpoint of the trading periods range.
Compare Nabriva Therapeutics to competition

Nabriva Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Nabriva Therapeutics stock to make a market-neutral strategy. Peer analysis of Nabriva Therapeutics could also be used in its relative valuation, which is a method of valuing Nabriva Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Nabriva Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Nabriva Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Nabriva Therapeutics shares will generate the highest return on investment. By undertsting and applying Nabriva Therapeutics stock market strength indicators, traders can identify Nabriva Therapeutics AG entry and exit signals to maximize returns.

Nabriva Therapeutics Risk Indicators

The analysis of Nabriva Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Nabriva Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting nabriva stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Consideration for investing in Nabriva Stock

If you are still planning to invest in Nabriva Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nabriva Therapeutics' history and understand the potential risks before investing.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Money Managers
Screen money managers from public funds and ETFs managed around the world
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities